5 results about "Drug cost" patented technology

1. Name of the product in this design: The main body of the graphical user interface for importing and displaying drug cost data in an electronic device. 2. Purpose of this design: An electronic device. 3. The key design features of this product are the graphical user interface in the electronic device for which protection is sought. 4. The image or photograph that best illustrates the key design points: Design 1, Change State Diagram 2. 5. Design 1 is designated as the basic design. 6. Purpose of the graphical user interface: The graphical user interface is used to import and display drug cost data. The graphical user interface requests protection for a portion used to import and display drug cost data. 7. Human-computer interaction method of graphical user interface: In response to the user touching or clicking the "Add Billing Period" button in the main view of Design 1, the graphical user interface changes from the main view of Design 1 to the changed state diagram 1 of Design 1 to display the data import page; in response to the user touching or clicking the "Upload File" button in the changed state diagram 1 of Design 1 after completing the billing period settings, the graphical user interface changes from the changed state diagram 1 to the changed state diagram 2 of Design 1 to display the uploaded drug cost data; in response to the user filling in the data to be edited in the changed state diagram 2 of Design 1, the graphical user interface changes from the changed state diagram 2 of Design 1 to the changed state diagram 3 of Design 1 to display the data entry result; in response to the user touching or clicking the "Done" button in the changed state diagram 3 of Design 1, the graphical user interface changes from the changed state diagram 3 of Design 1 to the changed state diagram 4 of Design 1 to display the imported drug cost data. In response to a user touching or clicking the "Add Billing Period" button in the main view of Design 2, the graphical user interface changes from the main view of Design 2 to Design 2 Change State Figure 1 to display the data import page; in response to a user touching or clicking the "Upload File" button in Design 2 Change State Figure 1 after completing the billing period settings, the graphical user interface changes from Design 2 Change State Figure 1 to Design 2 Change State Figure 2 to display the uploaded drug cost data; in response to a user filling in the data to be edited in Design 2 Change State Figure 2, the graphical user interface changes from Design 2 Change State Figure 2 to Design 2 Change State Figure 3 to display the data entry result; in response to a user touching or clicking the "Done" button in Design 2 Change State Figure 3, the graphical user interface changes from Design 2 Change State Figure 3 to Design 2 Change State Figure 4 to display the imported drug cost data. 8. Other situations requiring explanation: The portion of the graphical user interface shown by the dashed lines in the views of Design 1 to Design 2 does not constitute the part that is protected by this design.

1. Name of the product in this design: The main body of the graphical user interface for drug expense management of electronic equipment. 2. Purpose of this design: An electronic device. 3. The key design features of this product are the graphical user interface in the electronic device for which protection is sought. 4. The picture or photo that best illustrates the key design points: Design 1 front view. 5. Design 1 is designated as the basic design. 6. Purpose of the graphical user interface: The graphical user interface is used for drug cost management. The graphical user interface requests protection for a portion used for drug cost management. 7. Human-computer interaction method of the graphical user interface: In response to the user touching or clicking the "Full Screen" button in the main view of Design 1 to exit full screen, the graphical user interface changes from the main view of Design 1 to the state diagram of Design 1 to display the drug cost management system interface; in response to the user touching or clicking the "ATC Analysis" button in the state diagram of Design 1, the graphical user interface changes from the state diagram of Design 1 to the state diagram of Design 1 to display ATC analysis information; in response to the user touching or clicking the "Policy Analysis" button in the state diagram of Design 1, the graphical user interface changes from the state diagram of Design 1 to the state diagram of Design 1 to the state diagram of Design 1. The graphical user interface (GUI) changes from Design 1 Change State Figure 3 to Design 1 Change State Figure 4 to display department analysis information in response to user touch or click the "Department Analysis" button in Design 1 Change State Figure 4. Similarly, it changes from Design 1 Change State Figure 4 to Design 1 Change State Figure 5 to display drug cost overview information in response to user touch or click the "Drug Cost Overview" button in Design 1 Change State Figure 4. Finally, it changes from Design 1 Change State Figure 5 to Design 1 Change State Figure 6 to display more drug cost overview information in response to user swiping up the information display area in Design 1 Change State Figure 5. In response to a user touching or clicking the "Full Screen" button in the main view of Design 2 to exit full screen, the graphical user interface changes from the main view of Design 2 to Design 2 Change State Figure 1 to display the drug cost management system interface; in response to a user touching or clicking the "ATC Analysis" button in Design 2 Change State Figure 1, the graphical user interface changes from Design 2 Change State Figure 1 to Design 2 Change State Figure 2 to display ATC analysis information; in response to a user touching or clicking the "Policy Analysis" button in Design 2 Change State Figure 2, the graphical user interface changes from Design 2 Change State Figure 2 to Design 2 Change State Figure 3 to display policy analysis. Information; In response to a user touching or clicking the "Department Analysis" button in Design 2 Change State Diagram 3, the graphical user interface changes from Design 2 Change State Diagram 3 to Design 2 Change State Diagram 4 to display department analysis information; In response to a user touching or clicking the "Medication Cost Overview" button in Design 2 Change State Diagram 4, the graphical user interface changes from Design 2 Change State Diagram 4 to Design 2 Change State Diagram 5 to display medication cost overview information; In response to a user swiping up the information display area in Design 2 Change State Diagram 5, the graphical user interface changes from Design 2 Change State Diagram 5 to Design 2 Change State Diagram 6 to display more medication cost overview information. 8. Other situations requiring explanation: The portion of the graphical user interface shown by the dashed lines in the views of Design 1 to Design 2 does not constitute the part that is protected by this design.

To provide a patient support apparatus and method that present information that enables each patient to select medication receiving means according to preferences.SOLUTION: A patient support apparatus includes: means 110 that stores, for each prescription medication delivery means, service-available time, location information, an area where service can be provided, and an individual fee in association with each other; means 120 that stores drug identification information and a unit price of a drug in association with each other; means 160 that specifies delivery means in which a time designated by a patient is included in the service-available time and location information of the patient is included in the area where service can be provided; means 170 that specifies the individual fee for each specified delivery means; means 180 that calculates, for each specified delivery means, a required time until the drug is received; means 190 that calculates a drug price for the specified delivery means; and means 200 that calculates a patient payment amount, which is a total amount to be paid by the patient obtained by adding the individual fee to the drug price for each specified delivery means, and displays the required time and the patient payment amount so that the patient can view them in a list.SELECTED DRAWING: Figure 2

The invention provides a medication recommendation method and device, electronic equipment, a storage medium and a program product, and relates to the technical field of computers. According to the method, the diagnosis information of the patient is acquired from the hospital information system, the corresponding medical insurance disease group can be accurately matched, the medical insurance payment standard can be determined, close combination of a medication decision and a medical insurance policy is ensured, and medical insurance payment deviation caused by information asymmetry is avoided. Secondly, the cost interval is determined based on the medical insurance payment standard, the medicine cost of the patient and the preset medicine proportion upper limit, a clear cost reference range is provided for a doctor, the medical cost can be reasonably controlled, and unnecessary medical resource waste is reduced. Moreover, the target drug combination is determined by combining the diagnosis information, the cost interval and the hospital medication scheme database, the normalization and effectiveness of medication are considered, the rationality of the cost is also considered, and the optimal drug combination can be recommended for the patient. And finally, the target drug combination is pushed to a doctor end, so that intelligent decision support is provided for doctors, the standardization and consistency of doctor advices are improved, drug use deviation and medical dispute risks caused by manual selection are reduced, and the overall quality and efficiency of medical services are improved.

The present invention aims to treat only specific organs with a high concentration of a drug, thereby increasing the efficacy of the drug in those organs and eliminating side effects on other organs, while reducing the amount of drug used compared to systemic administration, thereby reducing drug costs. The present invention provides a pharmaceutical agent for administration to an organ in a subject's body that is independent of the bloodstream.